OOIR: Observatory of International Research

Papers

(The TQCC of Clinical Breast Cancer is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial	138
Patient-reported Outcomes of Patients With Breast Cancer During the COVID-19 Outbreak in the Epicenter of China: A Cross-sectional Survey Study	93
The Role of Immune Cells in Breast Tissue and Immunotherapy for the Treatment of Breast Cancer	86
Cancer-related Fatigue in Breast Cancer Survivors: A Review	71
A Phase II Study of Pembrolizumab in Combination With Palliative Radiotherapy for Hormone Receptor-positive Metastatic Breast Cancer	43
Effect of the COVID-19 Pandemic on Surgical Breast Cancer Care in the Netherlands: A Multicenter Retrospective Cohort Study	42
Effectiveness of a Smartphone Application as a Support Tool for Patients Undergoing Breast Cancer Chemotherapy: A Randomized Controlled Trial	40
Trastuzumab Deruxtecan (DS-8201a): The Latest Research and Advances in Breast Cancer	38
Epidemiology of De Novo Metastatic Breast Cancer	37
Aspirin Use and Risk of Breast Cancer: A Meta-analysis of Observational Studies from 1989 to 2019	36
Convolutional Neural Network Detection of Axillary Lymph Node Metastasis Using Standard Clinical Breast MRI	36
Characteristics, Clinical Differences and Outcomes of Breast Cancer Patients with Negative or Low HER2 Expression	34
Thermal Ablation as an Alternative for Surgical Resection of Small (≤ 2 cm) Breast Cancers: A Meta-Analysis	32
Can Breast Self-examination and Clinical Breast Examination Along With Increasing Breast Awareness Facilitate Earlier Detection of Breast Cancer in Populations With Advanced Stages at Diagnosis?	31
Circulating Biomarkers in Breast Cancer	30
T-DM1 Efficacy in Patients With HER2-positive Metastatic Breast Cancer Progressing After a Taxane Plus Pertuzumab and Trastuzumab: An Italian Multicenter Observational Study	28
Association Between One-carbon Metabolism-related Vitamins and Risk of Breast Cancer: A Systematic Review and Meta-analysis of Prospective Studies	27
Wnt/β-Catenin Signaling Pathway as Chemotherapeutic Target in Breast Cancer: An Update on Pros and Cons	27
Quality of Life and Early Functional Evaluation in Direct-to-Implant Breast Reconstruction After Mastectomy: A Comparative Study Between Prepectoral Versus Dual-Plane Reconstruction	27
A Systematic Literature Review of the Prognostic and Predictive Value of PIK3CA Mutations in HR+/HER2− Metastatic Breast Cancer	26
Expression Pattern and Prognostic Significance of Chemokines in Breast cancer: An Integrated Bioinformatics Analysis	26
Prognostic Significance of Androgen Receptor Expression in Triple Negative Breast Cancer: A Systematic Review and Meta-Analysis	26
Molecular Profiling of the Metaplastic Spindle Cell Carcinoma of the Breast Reveals Potentially Targetable Biomarkers	25
MicroRNA-4472 Promotes Tumor Proliferation and Aggressiveness in Breast Cancer by Targeting RGMA and Inducing EMT	24
Advances in Combining Radiation and Immunotherapy in Breast Cancer	24

nextMONARCH: Abemaciclib Monotherapy or Combined With Tamoxifen for Metastatic Breast Cancer	23
Cyclin-Dependent Kinase 4/6 Inhibitors Combined With Radiotherapy for Patients With Metastatic Breast Cancer	23
circCDYL Acts as a Tumor Suppressor in Triple Negative Breast Cancer by Sponging miR-190a-3p and Upregulating TP53INP1	22
Diagnostic Performance of Adjunctive Imaging Modalities Compared to Mammography Alone in Women with Non-Dense and Dense Breasts: A Systematic Review and Meta-Analysis	21
Convolutional Neural Network of Multiparametric MRI Accurately Detects Axillary Lymph Node Metastasis in Breast Cancer Patients With Pre Neoadjuvant Chemotherapy	21
Breast Conserving Surgery for BRCA Mutation Carriers—A Systematic Review	21
A Phase II Study of the Efficacy and Safety of Chloroquine in Combination With Taxanes in the Treatment of Patients With Advanced or Metastatic Anthracycline-refractory Breast Cancer	21
Regret and Quality of Life After Mastectomy With or Without Reconstruction	21
MINImal vs. MAXimal Invasive Axillary Staging and Treatment After Neoadjuvant Systemic Therapy in Node Positive Breast Cancer: Protocol of a Dutch Multicenter Registry Study (MINIMAX)	21
Pre- and Postoperative Neratinib for HER2-Positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium 022	21
Role of Superb Microvascular Imaging in Differentiating Between Malignant and Benign Solid Breast Masses	21
Feasibility of Axillary Lymph Node Localization and Excision Using Radar Reflector Localization	20
Progression-free Survival Outcome Is Independent of Objective Response in Patients With Estrogen Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative Advanced Breast Cancer Treated Wit	19
Controversial role of mast cells in breast cancer tumor progression and angiogenesis	19
Microablative Fractional CO2 Laser for Vulvovaginal Atrophy in Women With a History of Breast Cancer: A Pilot Study at 4-week Follow-up	19
Rapid Assessment of Resection Margins During Breast Conserving Surgery Using Intraoperative Flow Cytometry	19
MR Elastography of the Breast: Evolution of Technique, Case Examples, and Future Directions	19
A Review of Breast Density Implications and Breast Cancer Screening	18
Aromatherapy Plus Music Therapy Improve Pain Intensity and Anxiety Scores in Patients With Breast Cancer During Perioperative Periods: A Randomized Controlled Trial	18
Radiomics Model for Evaluating the Level of Tumor-Infiltrating Lymphocytes in Breast Cancer Based on Dynamic Contrast-Enhanced MRI	18
Complications in Post-mastectomy Immediate Breast Reconstruction: A Ten-year Analysis of Outcomes	18
Dietary Patterns and Risk of Invasive Ductal and Lobular Breast Carcinomas: A Systematic Review and Meta-analysis	17
Can the Neutrophil to Lymphocyte Ratio Predict Complete Pathologic Response to Neoadjuvant Breast Cancer Treatment? A Systematic Review and Meta-analysis	17
Can Low-cost Indo Cyanine Green Florescence Technique for Sentinel Lymph Node Biopsy Replace Dual Dye (Radio-colloid and Blue Dye) Technique in Early Breast Cancer: A Prospective Two-arm Comparative S	17
Birth Weight and Incidence of Breast Cancer: Dose-Response Meta-analysis of Prospective Studies	17
Pregnancy-Associated Breast Cancer: A Multidisciplinary Approach	17
Advances in Therapeutic Approaches for Triple-Negative Breast Cancer	17
Platelet/Lymphocyte Ratio Is Superior to Neutrophil/Lymphocyte Ratio as a Predictor of Chemotherapy Response and Disease-free Survival in Luminal B-like (HER2−) Breast Cancer	17
Direct to Implant Breast Reconstruction With Prepectoral Micropolyurethane Foam-Coated Implant: Analysis of Patient Satisfaction	16
Exosomal Del-1 as a Potent Diagnostic Marker for Breast Cancer: Prospective Cohort Study	16
Treatment Decision Making and Financial Toxicity in Women With Metastatic Breast Cancer	16
Male Breast Cancer Risk Assessment and Screening Recommendations in High-Risk Men Who Undergo Genetic Counseling and Multigene Panel Testing	16
Population-based Study of Prosigna-PAM50 and Outcome Among Postmenopausal Women With Estrogen Receptor-positive and HER2-negative Operable Invasive Lobular or Ductal Breast Cancer	16
Preliminary Results of a Randomized Study on Postmenopausal Women With Early Stage Breast Cancer: Adjuvant Hypofractionated Whole Breast Irradiation Versus Accelerated Partial Breast Irradiation (HYPA	15
Manual Lymphatic Drainage for Breast Cancer-related Lymphedema: A Systematic Review and Meta-analysis of Randomized Controlled Trials	15
Association Between Fatty Liver Index and Risk of Breast Cancer: A Nationwide Population-Based Study	15
Breast Lymphedema After Conservative Breast Surgery: An Up-to-date Systematic Review	15
Invasive Breast Cancer in a Trans Man After Bilateral Mastectomy: Case Report and Literature Review	15
Prognostic Value of Natural Killer Cells Besides Tumor-Infiltrating Lymphocytes in Breast Cancer Tissues	15
Clinical Features and Survival of Single Hormone Receptor–Positive Breast Cancer: A Population-Based Study of 531,605 Patients	15
Prevention of Breast Cancer-Related Lymphedema	14
Development of a Nomogram to Predict the Recurrence Score of 21-Gene Prediction Assay in Hormone Receptor–Positive Early Breast Cancer	14
Definition of Tumor Bed Boost in Oncoplastic Breast Surgery: An Understanding and Approach	14
Impact of Anti-HER2 Treatments Combined With Atezolizumab on the Tumor Immune Microenvironment in Early or Metastatic Breast Cancer: Results From a Phase Ib Study	13
Nomogram Predicting the Risk of Locoregional Recurrence After Mastectomy for Invasive Micropapillary Carcinoma of the Breast	13
Prognostic and Predictive Impact of Beta-2 Adrenergic Receptor Expression in HER2-Positive Breast Cancer	13
Lifestyle Characteristics in Women Carriers of BRCA Mutations: Results From an Italian Trial Cohort	13
Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio in Different Phenotypes of Locally Advanced Breast Cancer During Neoadjuvant Systemic Treatment	13
Deep Learning for the Detection of Breast Cancers on Chest Computed Tomography	13
Relationship Between the Neutrophil to Lymphocyte Ratio, Stromal Tumor-infiltrating Lymphocytes, and the Prognosis and Response to Neoadjuvant Chemotherapy in Triple-negative Breast Cancer	13

Nuances of PFKFB3 Signaling in Breast Cancer	13
An Update on the Molecular and Clinical Characteristics of Apocrine Carcinoma of the Breast	13
Molecular Classification of Triple Negative Breast Cancer and the Emergence of Targeted Therapies	13
Combined Complete Decongestive Therapy Reduces Volume and Improves Quality of Life and Functional Status in Patients With Breast Cancer-Related Lymphedema	13
Oncologic Safety of Autologous Fat Grafting in Breast Reconstruction	13
Aberrantly Methylated cfDNA in Body Fluids as a Promising Diagnostic Tool for Early Detection of Breast Cancer	13
Real-World Outcomes of Everolimus and Exemestane for the Treatment of Metastatic Hormone Receptor-Positive Breast Cancer in Patients Previously Treated With CDK4/6 Inhibitors	13
Breast Cancer Provider Interval Length in Fukushima, Japan, After the 2011 Triple Disaster: A Long-Term Retrospective Study	12
Magnetic Seeds: An Alternative to Wire Localization for Nonpalpable Breast Lesions	12
Impact of the Delayed Initiation of Adjuvant Chemotherapy in the Outcome of Triple Negative Breast Cancer	12
Interventional Ductoscopy as an Alternative for Major Duct Excision or Microdochectomy in Women Suffering Pathologic Nipple Discharge: A Single-center Experience	12
The Influence of Hormone Therapy on secondary diabetes mellitus in Breast Cancer: A Meta-analysis	12
The Cardioprotective Effect of Vitamin D in Breast Cancer Patients Receiving Adjuvant Doxorubicin Based Chemotherapy	12
Discordance Between Immunohistochemistry and In Situ Hybridization to Detect HER2 Overexpression/Gene Amplification in Breast Cancer in the Modern Age: A Single Institution Experience and Pooled Liter	12
Late-Stage Diagnosis and Associated Factors Among Breast Cancer Patients in South and Southwest Ethiopia: A Multicenter Study	12
Neuromuscular, Psychological, and Sleep Predictors of Cancer-Related Fatigue in Cancer Patients	11
Five-Year Adjuvant Endocrine Therapy Adherence Trajectories Among Women With Breast Cancer: A Nationwide French Study Using Administrative Data	11
A Phase Ib Dose Escalation Trial of RO4929097 (a γ-secretase inhibitor) in Combination with Exemestane in Patients with ER + Metastatic Breast Cancer (MBC)	11
Circ-RPPH1 knockdown retards breast cancer progression via miR-328-3p-mediated suppression of HMGA2	11
Invasive Breast Cancer Treatment Patterns in Women Age 80 and Over: A Report from the National Cancer Database	11
Network Meta-analysis for the Diagnostic Approach to Pathologic Nipple Discharge	11
Breast Cancer Management During COVID-19 Pandemic in Madrid: Surgical Strategy	11
Breast Conserving Surgery Compared With Mastectomy in Male Breast Cancer: A Brief Systematic Review	11
Combining Adjuvant Radiotherapy With Capecitabine in Chemotherapy-resistant Breast Cancer: Feasibility, Safety, and Toxicity	11
YY1-Induced Transcriptional Activation of FAM111B Contributes to the Malignancy of Breast Cancer	11
A Predictor of Early Disease Recurrence in Patients With Breast Cancer Using a Cell-free RNA and Protein Liquid Biopsy	11
Neoadjuvant Chemotherapy for Metaplastic Breast Cancer: Response Rates, Management, and Outcomes	11
A Phase I/Ib Trial of PD 0332991 (Palbociclib) and T-DM1 in HER2-Positive Advanced Breast Cancer After Trastuzumab and Taxane Therapy	10
Predictors of Whole Breast Radiation Therapy Completion in Early Stage Breast Cancer Following Lumpectomy	10
The Role of Contrast-Enhanced Ultrasound in the Diagnosis and Pathologic Response Prediction in Breast Cancer: A Meta-analysis and Systematic Review	10
Electronic Patient-reported Outcomes During Breast Cancer Adjuvant Radiotherapy	10
Ductal Carcinoma in Situ: A French National Survey. Analysis of 2125 Patients	10
Incidence and Severity of Myelosuppression With Palbociclib After Palliative Bone Radiation in Advanced Breast Cancer: A Single Center Experience and Review of Literature	10
Impact of Body Mass Index on Outcomes After Breast Cancer Surgery: Nationwide Inpatient Database Study in Japan	10
Higher Risk of Depression After Total Mastectomy Versus Breast Reconstruction Among Adult Women With Breast Cancer: A Systematic Review and Metaregression	10
Case-Based Review and Clinical Guidance on the Use of Genomic Assays for Early-Stage Breast Cancer: Breast Cancer Therapy Expert Group (BCTEG)	10
Updates in Neoadjuvant Therapy for Triple Negative Breast Cancer	10
Overall Survival in Metastatic Breast Cancer Patients in the Third Millennium: Results of the COSMO Study	10
A Roundtable Discussion of the Breast Cancer Therapy Expert Group (BCTEG): Clinical Developments and Practice Guidance on Human Epidermal Growth Factor Receptor 2 (HER2)-positive Breast Cancer	10
The Impact of Postoperative Wound Complications on Oncological Outcomes Following Immediate Breast Reconstruction for Breast Cancer: A Meta-analysis	10
Microbiome Assisted Tumor Microenvironment: Emerging Target of Breast Cancer	10
Real-World Treatment Patterns and Outcomes of Palbociclib Plus an Aromatase Inhibitor for Metastatic Breast Cancer: Flatiron Database Analysis	10
Hypofractionated Whole Breast Irradiation and Simultaneous Integrated Boost in Large-breasted Patients: Long-term Toxicity and Cosmesis	10
Impact of ESR1 Polymorphisms on Risk of Breast Cancer in the Chinese Han Population	9
MRI Response to Pre-operative Stereotactic Ablative Body Radiotherapy (SABR) in Early Stage ER/PR+ HER2- Breast Cancer correlates with Surgical Pathology Tumor Bed Cellularity	9
Nine-Year Median Follow-up of Cardiotoxicity and Efficacy of Trastuzumab Concurrently With Anthracycline-Based and Anthracycline-Free Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer Patients	9
Pathology of BRCA1- and BRCA2-associated Breast Cancers: Known and Less Known Connections	9
Factors Associated With Breast Cancer Surgery Delay Within a Coordinated Multihospital Community Health System: When Does Surgical Delay Impact Outcome?	9
Prognostic Model and Nomogram for Estimating Survival of Small Breast Cancer: A SEER-based Analysis	9
Bone-modifying Agents (BMAs) in Breast Cancer	9
A First-in-Human Phase 1 Study of a Novel Selective Androgen Receptor Modulator (SARM), RAD140, in ER+/HER2- Metastatic Breast Cancer	9
Predicting Thrombocytopenia in Patients With Breast Cancer Treated With Ado-trastuzumab Emtansine	9
Real-world Outcomes of Cyclin-dependent Kinase Inhibitors Continued Beyond First Disease Progression in Hormone Receptor-positive Metastatic Breast Cancer	9
Targeting PIK3CA Alterations in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2–Negative Advanced Breast Cancer: New Therapeutic Approaches and Practical Considerations	9
Long-Term Oncologic Safety of Nipple-Sparing Mastectomy With Immediate Reconstruction	9
CXCL8 Facilitates the Survival and Paclitaxel-Resistance of Triple-Negative Breast Cancers	9
Intraoperative Ultrasound and Oncoplastic Combined Approach: An Additional Tool for the Oncoplastic Surgeon to Obtain Tumor-Free Margins in Breast Conservative Surgery—A 2-Year Single-Center Prospecti	9
The Role of Breast Cancer Stem Cells and Some Related Molecular Biomarkers in Metastatic and Nonmetastatic Breast Cancer	9
An individual participant data meta-analysis of breast cancer detection and recall rates for digital breast tomosynthesis versus digital mammography population screening	9
MicroRNA-432 Acts as a Prognostic Biomarker and an Inhibitor of Cell Proliferation, Migration, and Invasion in Breast Cancer	8
Effect of Surgery at Primary and Metastatic Sites in Patients With Stage IV Breast Cancer	8
Improving the Diagnostic Accuracy of Breast BI-RADS 4 Microcalcification-Only Lesions Using Contrast-Enhanced Mammography	8
A N0 Predicting Model for Sentinel Lymph Node Biopsy Omission in Early Breast Cancer Upstaged From Ductal Carcinoma in Situ	8
Association of Serum Progranulin Levels With Disease Progression, Therapy Response and Survival in Patients With Metastatic Breast Cancer	8
Severe Impact of Covid-19 Pandemic on Breast Cancer Care in Italy: A Senonetwork National Survey	8
AGR2 and AGR3 play an important role in the clinical characterization and prognosis of basal like breast cancer	8
Real-world Evidence of Diagnostic Testing and Treatment Patterns in US Patients With Breast Cancer With Implications for Treatment Biomarkers From RNA Sequencing Data	8
The Effects of HER2 on CDK4/6 Activity in Breast Cancer	8
Axillary Reverse Mapping in the Prevention of Lymphoedema: A Systematic Review and Pooled Analysis	8
Ultrasound and Clinical Characteristics of False-negative Results in Mammography Screening of Dense Breasts	8
Liver Metastases-directed Therapy in the Management of Oligometastatic Breast Cancer	8
Newly Approved and Emerging Agents in HER2-Positive Metastatic Breast Cancer	8
Werner Syndrome Protein Expression in Breast Cancer	8
Radiomic Nomogram for Pretreatment Prediction of Pathologic Complete Response to Neoadjuvant Therapy in Breast Cancer: Predictive Value of Staging Contrast-enhanced CT	7
Durable Clinical Activity to the AKT Inhibitor Ipatasertib in a Heavily Pretreated Patient With an AKT1 E17K Mutant Metastatic Breast Cancer	7
Markers of Cardiotoxicity in Early Breast Cancer Patients Treated With a Hypofractionated Schedule: A Prospective Study	7
The Upgrade Risk of B3 Lesions to (Pre)Invasive Breast Cancer After Diagnosis on Core Needle or Vacuum Assisted Biopsy. A Belgian National Cohort Study	7
Nomogram for Predicting the Overall Survival of Patients With Breast Cancer With Pathologic Nodal Status N3	7
The Influence of Histologic Grade on Outcomes of Elderly Women With Early Stage Breast Cancer Treated With Breast Conserving Surgery With or Without Radiotherapy	7
Validation of CTS5 on a Retrospective Cohort of Real-Life Pre- and Postmenopausal Patients Diagnosed With Estrogen Receptor–Positive Breast Cancers: Is It Prognostic?	7

Regional Nodal Irradiation for Clinically Node-Positive Breast Cancer Patients With Pathologic Negative Nodes After Neoadjuvant Chemotherapy	7
Acquisition of Cabozantinib-Sensitive MET D1228N Mutation During Progression on Crizotinib in MET-Amplified Triple-Negative Breast Cancer	7
Breast Cancer Stem Cells-derived Extracellular Vesicles Affect PPARG Expression by Delivering MicroRNA-197 in Breast Cancer Cells	7
Health Care Disparities and Demand for Expanding Hereditary Breast Cancer Screening Guidelines in African Americans	7
Metabolic Syndrome and Risk of Breast Cancer by Molecular Subtype: Analysis of the MEND Study	7
Metastatic Presentations of Previously Treated Early-Stage Breast Cancer Patients and Association With Survival	7
Effect of MicroRNA-766 Promotes Proliferation, Chemoresistance, Migration, and Invasion of Breast Cancer Cells	7
Radiotherapy Utilization for Patients Over Age 60 With Early Stage Breast Cancer	7
The Fanconi anemia pathway and Breast Cancer: A comprehensive review of clinical data	7
Ipsilateral Breast Cancer Recurrence: Characteristics, Treatment, and Long-Term Oncologic Results at a High-Volume Center	7
Evaluation of Tucatinib in HER2-Positive Breast Cancer Patients With Brain Metastases: A United States-Based Cost-Effectiveness Analysis	7
Comparison of Spinal Alignment and Mobility in Women With and Without Post Modified Radical Mastectomy Unilateral Lymphoedema	7
Real-world Data on First-line Systemic Therapy for Hormone Receptor-positive HER2-negative Metastatic Breast Cancer: A Trend Shift in the Era of CDK 4/6 Inhibitors	7
Endocrine Therapy With or Without CDK4/6 Inhibitors in Women With Hormone-receptor Positive Breast Cancer: What do we Know About the Effects on Cognition?	7
Optimal Strategies for Successful Initiation of Neratinib in Patients with HER2-Positive Breast Cancer	7
A 10-Gene Signature for Predicting the Response to Neoadjuvant Trastuzumab Therapy in HER2-Positive Breast Cancer	7
Impact of the 21-Gene Recurrence Score Assay on the Treatment of Estrogen Receptor-Positive, HER2-Negative, Breast Cancer Patients With 1-3 Positive Nodes: A Prospective Clinical Utility Study	7
Evaluation of the Learning Curve in Robotic Nipple-sparing Mastectomy for Breast Cancer	7
The Impact of Locoregional Treatment on Survival in Patients With Metastatic Breast Cancer: A National Cancer Database Analysis	7
Barriers to Clinical Trial Accrual: Perspectives of Community-Based Providers	7
First-line Treatment with Ribociclib plus Endocrine Therapy for Premenopausal Women with Hormone-receptor-positive Advanced Breast Cancer: A Cost-effectiveness Analysis	7
Gender Disparity in Breast Cancer: A Veteran Population-Based Comparison	7
Time to Update Evidence-Based Guideline Recommendations About Concurrent Tamoxifen and Antidepressant Use? A Systematic Review	7
A Genetic Variant of the BTLA Gene is Related to Increased Risk and Clinical Manifestations of Breast Cancer in Chinese Women	7
Breast-Conserving Surgeries With and Without Cavity Shave Margins Have Different Re-excision Rates and Associated Overall Cost: Institutional and Patient-Driven Decisions for Its Utilization	7
RUNX1 as a Novel Molecular Target for Breast Cancer	7
Current Status and Problems of Breast Cancer Treatment with Schizophrenia	7
Adherence to the MIND Diet and Risk of Breast Cancer: A Case-control Study	7
Comparison of the Efficacy, Safety, Pharmacokinetic and Immunogenicity of UJVIRA (ZRC-3256, Trastuzumab Emtansine) With the Kadcyla (Trastuzumab Emtansine) in the Treatment of HER2-Positive Metastatic	7
Three-year Trends in Diagnosis of B3 Breast Lesions and Their Upgrade Rates to Malignant Lesions	7
Primary and Secondary Breast Sarcoma: Clinical and Pathological Characteristics, Prognostic Factors, and Nomograms for Predicting Survival	7
Characterization of Weakly Hormone Receptor (HR)-Positive, HER2-Negative Breast Cancer and Current Treatment Strategies	6
Combined Use of Immunoreactivities of RIG-I with Efp/TRIM25 for Predicting Prognosis of Patients With Estrogen Receptor-positive Breast Cancer	6
Capecitabine-Based Chemoendocrine Combination as First-Line Treatment for Metastatic Hormone-Positive Metastatic Breast Cancer: Phase 2 Study	6
Extended Clinical Experience With Nipple-Sparing Mastectomy and Prepectoral Polyurethane Implant Positioning (BRAND4P method)	6
Effect of Breast Conservation Therapy vs Mastectomy on Overall Survival and Breast Cancer-Specific Survival Among Men With Stage I-II Breast Cancer: Analysis of SEER, 2000-2018	6
Significance of Non-Mass Enhancement in the Subareolar Region on Preoperative Breast Magnetic Resonance Imaging for Nipple-Sparing Mastectomy	6
Has Hypofractionated Whole-Breast Radiation Therapy Become the Standard of Care in the United States? An Updated Report from National Cancer Database	6
Identification of Novel Diagnostic Biomarkers in Breast Cancer Using Targeted Metabolomic Profiling	6
Survival in Women Diagnosed With Breast Cancer During Pregnancy	6
Clinical Contribution of Next-Generation Sequencing Multigene Panel Testing for BRCA Negative High-Risk Patients With Breast Cancer	6
Diagnosis of Leptomeningeal Metastasis in Women With Breast Cancer Through Identification of Tumor Cells in Cerebrospinal Fluid Using the CNSide™ Assay	6
Big Data Solutions for Controversies in Breast Cancer Treatment	6
Meta-Analysis of Breast Cancer Risk in Levonorgestrel-Releasing Intrauterine System Users	6
The Effect of Supplemental Imaging on Interval Cancer Rates in Mammography Screening: Systematic Review	6
A Systematic Comparison of Overall Survival Between Men and Women With Triple Negative Breast Cancer	6
Oral Endocrine Therapy Agent, Race/Ethnicity, and Time on Therapy Predict Adherence in Breast Cancer Patients in a Large Academic Institution	6
Nomogram Based on Breast MRI and Clinicopathologic Features for Predicting Axillary Lymph Node Metastasis in Patients with Early-Stage Invasive Breast Cancer: A Retrospective Study	6
Cancer Stem Cells and Circulatory Tumor Cells Promote Breast Cancer Metastasis	6
The Pretreatment Systemic Inflammation Response Index as a Useful Prognostic Factor is Better Than Lymphocyte to Monocyte Ratio in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy	6
Survival among Breast Cancer Patients: Comparison of the U.S. Military Health System with the Surveillance, Epidemiology and End Results Program	6
New Cardiac Abnormalities After Radiotherapy in Breast Cancer Patients Treated With Trastuzumab	6
Symptom Burden Associated With Radiation Dermatitis in Breast Cancer Patients Undergoing Radiotherapy	6
Incidence and Survival by Human Epidermal Growth Factor Receptor 2 Status in Young Women With Stage I-III Breast Cancer: SEER, 2010-2016	6
Molecular Imaging of HER2 Expression in Breast Cancer patients Using the [99mTc] Tc-Labeled Small Peptide	6
A Review of Treatment-Induced Pulmonary Toxicity in Breast Cancer	6
Predicting Mastectomy Skin Flap Necrosis: A Systematic Review of Preoperative and Intraoperative Assessment Techniques	6
Novel Association of IGF2BP2 Gene Variants With Altered Risk of Breast Cancer and as Potential Molecular Biomarker of Triple Negative Breast Cancer	6
Risk of Recurrence in Patients With HER2+ Early-Stage Breast Cancer: Literature Analysis of Patient and Disease Characteristics	6
Comparison of Shoulder-Arm Complex Pain, Function, and Scapular Dyskinesia in Women With and Without Unilateral Lymphedema After Breast Cancer Surgery	6